Resistance to Targeted Therapies in Lymphomas

• Corporate Author: SpringerLink (Online service)
• Other Authors: Xavier, Ana C. (Editor, http://id.loc.gov/vocabulary/relators/edt), Cairo, Mitchell S. (Editor, http://id.loc.gov/vocabulary/relators/edt)
• Format: Electronic eBook
• Language: English
• Published: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Edition: 1st ed. 2019.
• Series: Resistance to Targeted Anti-Cancer Therapeutics, 21
• Subjects: Cancer research.; Cancer Research.

This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help...

Table of Contents:

• Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies
• Resistance to Monoclonal Antibody Therapeutics in Lymphoma
• Resistance to Antibody-Drug Conjugate
• Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma
• Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma
• Resistance to Bruton's Tyrosine Kinase Signaling Pathway Targeted Therapies
• Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
• Resistance to Bispecific T-cell Engagers and Bispecific Antibodies
• Resistance to Chimeric antigen receptor T-cell therapy
• Index.